title: Impact of metformin on the progression of MGUS to multiple myeloma.
authors.affiliation: a Abramson Cancer Center, Division of Hematology-Oncology , University of Pennsylvania , Philadelphia , PA , USA.|b Department of Biostatistics and Epidemiology , University of Pennsylvania , Philadelphia , PA , USA.
authors.forename: Ben
authors.initials: B
authors.lastname: Boursi
authors.affiliation: a Abramson Cancer Center, Division of Hematology-Oncology , University of Pennsylvania , Philadelphia , PA , USA.|b Department of Biostatistics and Epidemiology , University of Pennsylvania , Philadelphia , PA , USA.
authors.forename: Ronac
authors.initials: R
authors.lastname: Mamtani
authors.affiliation: b Department of Biostatistics and Epidemiology , University of Pennsylvania , Philadelphia , PA , USA.|c Division of Gastroenterology , University of Pennsylvania , Philadelphia , PA , USA.
authors.forename: Yu-Xiao
authors.initials: YX
authors.lastname: Yang
authors.affiliation: a Abramson Cancer Center, Division of Hematology-Oncology , University of Pennsylvania , Philadelphia , PA , USA.
authors.forename: Brendan M
authors.initials: BM
authors.lastname: Weiss
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D016022:Case-Control Studies; D018450:Disease Progression; D006801:Humans; D015994:Incidence; D008687:Metformin / Q000494:pharmacology* / Q000627:therapeutic use; D008998:Monoclonal Gammopathy of Undetermined Significance / Q000188:drug therapy / Q000453:epidemiology* / Q000473:pathology*; D009101:Multiple Myeloma / Q000453:epidemiology* / Q000473:pathology; D016017:Odds Ratio; D011159:Population Surveillance; D020011:Protective Agents / Q000494:pharmacology / Q000627:therapeutic use; D006113:United Kingdom / Q000453:epidemiology
chemical_list: D000970:Antineoplastic Agents; D020011:Protective Agents; D008687:Metformin